Similar articles

• Long-term follow-up of patients with NAFLD and elevated liver enzymes.

  Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Ekstedt M, et al. Hepatology. 2006 Oct;44(4):865-73. doi: 10.1002/hep.21327. Hepatology. 2006. PMID: 17006923
• Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

  Ong JP, Pitts A, Younossi ZM. Ong JP, et al. J Hepatol. 2008 Oct;49(4):608-12. doi: 10.1016/j.jhep.2008.06.018. Epub 2008 Jul 9. J Hepatol. 2008. PMID: 18682312
• Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?

  Roberts EA. Roberts EA. J Hepatol. 2007 Jun;46(6):1133-42. doi: 10.1016/j.jhep.2007.03.003. Epub 2007 Mar 26. J Hepatol. 2007. PMID: 17445934 Review.
• Natural history of nonalcoholic steatohepatitis.

  Liou I, Kowdley KV. Liou I, et al. J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S11-6. doi: 10.1097/01.mcg.0000168644.23697.31. J Clin Gastroenterol. 2006. PMID: 16540761 Review.
• Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.

  Rubinstein E, Lavine JE, Schwimmer JB. Rubinstein E, et al. Semin Liver Dis. 2008 Nov;28(4):380-5. doi: 10.1055/s-0028-1091982. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956294 Review.